The 3 linked references in paper D. Lukyantseva V., L. Mel’nikova S., A. Tatarinov P., Д. Лукьянцева В., Л. Мельникова С., А. Татаринов П. (2018) “МЕЖДУНАРОДНЫЙ ОПЫТ ЛЕКАРСТВЕННОГО ОБЕСПЕЧЕНИЯ НАСЕЛЕНИЯ В АМБУЛАТОРНОМ СЕКТОРЕ // THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT” / spz:neicon:pharmacoeconomics:y:2017:i:4:p:44-52

  1. Statistics Netherlands (2015). StatLine [online database]. The Hague/Heerlen: Statistics Netherlands. http://statline.cbs.nl. Accessed: 25.10.2017.
  2. Pomey M. P. et al. Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec’s universal drug insurance program, with comparisons to the medicare Prescription Drug program. Milbank Quarterly. 2007; 85 (3): 469-498.
  3. Department of Health (2013). Government agrees breakthrough drug pricing deal with pharmaceutical firms. London, Department of Health. URL: https://www.gov.uk/government/news/governmentagrees-breakthrough-drug-pricing-deal-with-pharmaceutical-firms. Accessed: 25.10.2017.